NASDAQ · LFWD
Healthcare · Medical - Devices
$7.12
Down-$0.01 (-0.14%)
Updated Sep 14, 2026, 7:32 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 18 trading sessions · Daily adjusted prices
LFWD closed at $7.12 after 18 trading sessions, down 3.65% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $7.39 | $7.39 | $7.1201 | $7.1201 | 936.6 |
| Sep 10, 2026 | $7.12 | $7.15 | $7.12 | $7.13 | 2.43K |
| Sep 8, 2026 | $6.99 | $7.40 | $6.99 | $7.40 | 4.3K |
| Sep 4, 2026 | $7.105 | $7.105 | $6.98 | $6.98 | 7.61K |
| Sep 3, 2026 | $7.27 | $7.3317 | $7.03 | $7.10 | 4.24K |
| Sep 2, 2026 | $7.21 | $7.26 | $7.10 | $7.26 | 3.48K |
| Sep 1, 2026 | $7.53 | $7.575 | $7.20 | $7.20 | 5.57K |
| Aug 31, 2026 | $7.47 | $7.6829 | $7.41 | $7.65 | 5.4K |
| Aug 28, 2026 | $7.30 | $7.50 | $7.20 | $7.46 | 4.41K |
| Aug 27, 2026 | $7.535 | $7.67 | $7.365 | $7.365 | 5.34K |
| Aug 26, 2026 | $7.30 | $7.49 | $7.30 | $7.49 | 2.48K |
| Aug 25, 2026 | $7.39 | $7.54 | $7.2822 | $7.39 | 3.8K |
| Aug 24, 2026 | $7.415 | $7.475 | $7.10 | $7.29 | 9.52K |
| Aug 21, 2026 | $7.41 | $7.505 | $7.32 | $7.32 | 8.91K |
| Aug 20, 2026 | $7.3599 | $7.37 | $7.19 | $7.33 | 5.99K |
| Aug 19, 2026 | $7.29 | $7.585 | $7.20 | $7.27 | 9.4K |
| Aug 18, 2026 | $7.33 | $7.43 | $7.255 | $7.4078 | 4.44K |
| Aug 17, 2026 | $7.25 | $7.7044 | $7.25 | $7.39 | 8.26K |
The latest Smart Investors Daily articles mentioning LFWD.
LFWD research
Company profile and research snapshot.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 19, 2026 | HC Wainwright & Co. | Buy | — |
| Nov 18, 2025 | HC Wainwright & Co. | Buy | — |
| Mar 11, 2025 | HC Wainwright & Co. | Buy | — |
| Mar 11, 2025 | Lake Street | Buy | — |
| Feb 20, 2025 | Lake Street | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 14, 2026
Lifeward (NASDAQ:LFWD) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(1.34) by 8.96 percent. This is a 61.07 percent increase over losses of $(3.75) per share from the
Benzinga · Mar 11, 2026
Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced it has received a
Benzinga · Feb 25, 2026
Benzinga · Feb 25, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning LFWD.
